Health Force Raises $4.8M for Hospital Operations AI

Fadi Haddad is financing a bet that European hospitals will buy operational capacity from software before they replace the systems they already own. Health Force has raised €4.2M in Seed funding, approximately $4.8M at the European Central Bank's September 17 reference rate, to scale AI agents that complete administrative work inside existing hospital software.

LUMO Labs led the round, with Step Venture, Next Tier Ventures, Target Global and Calm/Storm participating. The Barcelona company plans to expand its agent catalogue, grow engineering and delivery, and enter Germany, France and Spain.

The investment matters because Europe does not have a shortage of hospital dashboards. It has a shortage of operating capacity. WHO/Europe estimated in June 2026 that the European Region could face a shortage of nearly 1M health workers by 2030, while hospitals still rely on people to move authorizations, claims, reports and other cases across fragmented systems.

What Health Force raised and who backed it

Health Force announced the €4.2M Seed round on September 17, 2026. The dollar figure is approximately $4.8M using the ECB's 1.1481 USD-per-euro reference rate for that date. The company did not disclose its valuation, ownership terms, exact closing date or board rights.

LUMO Labs led the financing. Step Venture, Next Tier Ventures, Target Global and Calm/Storm also invested. Target Global said in the official announcement that it had backed Health Force at pre-seed, but no authoritative source disclosed the amount of that earlier financing or a reliable total-capital figure.

Health Force says it was founded in 2022. The company is headquartered in Barcelona and operates a delivery hub in Milan. Its current leadership includes Fadi Haddad, Co-Founder and CEO; Dr. Juan Suárez, Co-Founder and CPO; and Andrew Kochura, CTO.

The product is work completed inside existing systems

Health Force builds AI agents for prior-authorization checks, claims processing, regulatory reporting and other hospital operations. The agents use credentials to work inside systems already deployed by the hospital, follow defined rules, record their actions and route exceptions to staff. The company describes its architecture as deterministic-first and supervised by hospital teams.

That design is a commercial choice as much as a technical one. Replacing a hospital's core systems can become a multiyear procurement, migration and change-management program. Health Force is trying to create value before that replacement happens by operating the installed software like another member of the administrative team.

The company reports that its agents handle work behind more than 200,000 patient cases annually. It also says 3 out of 4 cases finish end to end without human touch, while the remaining cases arrive with the relevant work prepared for staff review. These are company-reported operating metrics, not independently audited results, but they describe the unit of value Health Force wants buyers to measure: completed cases rather than software seats.

Where the agents are working

The funding announcement names Humanitas and Gruppo San Donato among Health Force's hospital relationships in Italy. It also describes the platform supporting hospital quality reporting in Portugal. Health Force's website says the company can move from system access to production in about 6 weeks without requiring a new hospital interface or a mandatory API integration.

The company's public pages display different snapshots of the number of hospitals in production, so the total is not treated here as a settled metric. The named hospital groups, country deployments and annual case volume offer the more useful evidence. They place the product inside real operational workflows while leaving customer-level economics, retention, error rates and independently measured return on investment unresolved.

Health Force also says actions are logged and traceable, a requirement that becomes more important as the software moves from preparing information to completing work. A dashboard can be wrong and wait for a person to notice. An agent that submits a claim or regulatory report has already entered the operating chain, where permissions, exception handling and review design determine whether automation reduces pressure or simply relocates it.

Why hospital operations are becoming an AI market

WHO/Europe estimates that the European Region could face a shortage of nearly 1M health workers by 2030. Automation cannot train clinicians, repair workforce policy or remove the need for human judgment. It can affect how much repetitive administrative volume a scarce team must absorb before care even begins.

That pressure changes the enterprise-AI sales conversation. Hospitals do not need a demonstration that a model can generate text. They need evidence that a system can enter an existing workflow, apply local rules, preserve traceability, escalate the right exceptions and survive the ordinary disorder of hospital operations. The product must cross technical, regulatory and organizational boundaries without asking staff to become its integration layer.

Health Force's investors are therefore backing more than an AI application. They are backing a managed operating layer for a sector where replacing the underlying software may be slower than expanding demand. The investment case rests on whether one platform can learn enough country and workflow variation to reuse its deployment model without making each new hospital a custom-services project.

What the Seed capital changes

Health Force plans to extend its catalogue into quality reporting, clinical-trial operations and resource optimization. It will also add engineering and delivery capacity and expand into Germany, France and Spain, taking a model already used in Italy and Portugal into markets with different systems and reporting rules.

The expansion will test the company's central claim. If Health Force can preserve supervision and traceability while adapting the same agent platform across countries, it can sell hospitals a growing catalogue of completed workflows through one relationship. If every deployment requires substantial reinvention, the economics will look more like specialized implementation services than repeatable software.

The round gives Haddad, Suárez, Kochura and their team room to work through that tension while the customer pressure remains immediate. Each added workflow will deepen the product only if hospital staff can see what the agent did, understand what it escalated and trust the handoff when a case no longer fits the rule. Every new deployment will leave the practical record that matters: which cases finished, which escalated, and whether hospital teams gained capacity without surrendering visibility into the work.